---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-274193"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2025-11-10T23:59:59+00:00"
generated_at: "2026-05-16T22:20:42.088681+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Outset Medical Q3 revenue $29.4M (+3%); cuts FY 2025 revenue guidance to $115-120M

## Summary
- Net loss $17.8M vs $27.9M a year ago; non-GAAP net loss $12M vs $20.2M.
- Gross margin expanded to 39.4% (non-GAAP 39.9%) from 34.3% a year ago.
- FY 2025 revenue guidance reduced to $115-120M from prior $122-126M.
- Cash use improved to <$6M in Q3; total cash $182M at quarter end.
- Operating expenses declined 19% YoY to $27.4M; path to profitability focus.

## SEC filing metadata
- accession: 0001193125-25-274193
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2025-11-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000119312525274193/0001193125-25-274193-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000119312525274193/om-20251110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-274193
- JSON: https://secwatch.observer/filing/0001193125-25-274193.json
- Plain text: https://secwatch.observer/filing/0001193125-25-274193.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.